Infected cell protein No. 22 is subject to proteolytic cleavage by caspases activated by a mutant that induces apoptosis

Virology

Volumn 305, Issue 2, 2003, Pages 364-370

  Munger, Joshua ^a   Hagglund, Ryan ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 3; CASPASE INHIBITOR; INFECTED CELL PROTEIN 22; POLYPEPTIDE; PROTEIN BCL 2; PROTEIN KINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; BACULOVIRUS; CELL STRAIN; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC CODE; HEP 2 CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA CLEAVAGE; VIRUS GENE; VIRUS INFECTION; VIRUS MUTANT; WILD TYPE;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0037455540     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1728     Document Type: Article

References (30)

1. Advani S. J., Weichselbaum R. R., Roizman B. The role of cdc2 in the expression of herpes simplex virus genes. Proc. Natl. Acad. Sci. USA. 97:2000;10996-11001.
2. Asano S., Honda T., Goshima F., Nishiyama Y., Sugiura Y. US3 protein kinase of herpes simplex virus protects primary afferent neurons from virus-induced apoptosis in ICR mice. Neurosci. Lett. 294:2000;105-108.
3. Asano S., Honda T., Goshima F., Watanabe D., Miyake Y., Sugiura Y., Nishiyama Y. US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J. Gen. Virol. 80:1999;51-56.
4. Aubert M., Blaho J. A. The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J. Virol. 73:1999;2803-2813.
5. Aubert M., O'Toole J., Blaho J. A. Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J. Virol. 73:1999;10359-10370.
6. Carter K. L., Roizman B. The promoter and transcriptional unit of a novel herpes simplex virus 1 alpha gene are contained in, and encode a protein in frame with, the open reading frame of the alpha 22 gene. J. Virol. 70:1996;172-178.
7. Condreay J. P., Witherspoon S. M., Clay W. C., Kost T. A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. USA. 96:1999;127-132.
8. DeLuca N. A., McCarthy A. M., Schaffer P. A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56:1985;558-570.
9. Ejercito P. M., Kieff E. D., Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behavior of infected cells. J. Gen. Virol. 2:1968;357-364.
10. Galvan V., Brandimarti R., Munger J., Roizman B. Bcl-2 blocks a caspase-dependent pathway of apoptosis activated by herpes simplex virus 1 infection in HEp-2 cells. J. Virol. 74:2000;1931-1938.
11. Galvan V., Brandimarti R., Roizman B. Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. J. Virol. 73:1999;3219-3226.
12. Galvan V., Roizman B. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. USA. 95:1998;3931-3936.
13. Hagglund R., Munger J., Poon A. P., Roizman B. U(S)3 protein kinase of herpes simplex virus 1 blocks caspase 3 activation induced by the products of U(S)1.5 and U(L)13 genes and modulates expression of transduced U(S)1.5 open reading frame in a cell type-specific manner. J. Virol. 76:2002;743-754.
14. Hata S., Koyama A. H., Shiota H., Adachi A., Goshima F., Nishiyama Y. Antiapoptotic activity of herpes simplex virus type 2: The role of US3 protein kinase gene. Microbes Infect. 1:1999;601-607.
15. Jerome K. R., Fox R., Chen Z., Sears A. E., Lee H., Corey L. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J. Virol. 73:1999;8950-8957.
16. Koyama A. H., Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J. Virol. 71:1997;2567-2571.
17. Leopardi R., Roizman B. The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc. Natl. Acad. Sci. USA. 93:1996;9583-9587.
18. Leopardi R., Van Sant C., Roizman B. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. USA. 94:1997a;7891-7896.
19. Leopardi R., Ward P. L., Ogle W. O., Roizman B. Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase. J. Virol. 71:1997b;1133-1139.
20. Munger J., Chee A. V., Roizman B. The U(S)3 protein kinase blocks apoptosis induced by the d120 mutant of herpes simplex virus 1 at a premitochondrial stage. J. Virol. 75:2001;5491-5497.
21. Munger J., Roizman B. The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. 98:2001;10410-10415.
22. Ogle W. O., Roizman B. Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein. J. Virol. 73:1999;4305-4315.
23. Poffenberger K. L., Idowu A. D., Fraser-Smith E. B., Raichlen P. E., Herman R. C. A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo. Arch. Virol. 139:1994;111-119.
24. Purves F. C., Longnecker R. M., Leader D. P., Roizman B. Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J. Virol. 61:1987;2896-2901.
25. Purves F. C., Ogle W. O., Roizman B. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA. 90:1993;6701-6705.
26. Sieg S., Yildirim Z., Smith D., Kayagaki N., Yagita H., Huang Y., Kaplan D. Herpes simplex virus type 2 inhibition of Fas ligand expression. J. Virol. 70:1996;8747-8751.
27. Thornberry N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M., Houtzager V. M., Nordstrom P. A., Roy S., Vaillancourt J. P., Chapman K. T., Nicholson D. W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272:1997;17907-17911.
28. Zhou G., Galvan V., Campadelli-Fiume G., Roizman B. Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J. Virol. 74:2000;11782-11791.
29. Zhou G., Roizman B. Wild-type herpes simplex virus 1 blocks programmed cell death and release of cytochrome c but not the translocation of mitochondrial apoptosis-inducing factor to the nuclei of human embryonic lung fibroblasts. J. Virol. 74:2000;9048-9053.
30. Zhou G., Roizman B. The domains of glycoprotein D required to block apoptosis depend on whether glycoprotein D is present in the virions carrying herpes simplex virus 1 genome lacking the gene encoding the glycoprotein. J. Virol. 75:2001;6166-6172.